New drug cocktail aims to tame Tough-to-Treat blood cancer
NCT ID NCT04883242
Summary
This study is testing a combination of four medications for people with multiple myeloma that has come back or stopped responding to prior treatments. The goal is to see if this drug combination can effectively control the cancer and extend the time patients live without their disease getting worse. The trial involves about 30 participants and includes an initial treatment phase followed by a longer maintenance phase.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.